Patricia Gallego |

Patricia Gallego PhD leads Airfinity's COVID-19 analyst team, covering epidemiology, competitor and commercial intelligence across both treatments and vaccines. She has multiple years of experience in the biotechnology sector and a background in research at Imperial College London where she has published peer-reviewed papers on the relationship between chronic inflammation in Multiple Sclerosis and neurotransmission. As an excellent science communicator, Patricia has presented her research at international conferences and has given numerous talks to technical and non-specialist (public, MS patients, school children) audiences.